Last reviewed · How we verify

NCT04117386

Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium

Completed Last updated 14 July 2020
What this trial tests

trial testing HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) in Human Papilloma Virus Infection in 141 participants. Completed in 15 June 2020.

Timeline
1 January 2020
Primary endpoint
30 April 2020
15 June 2020

Quick facts

Lead sponsorChulalongkorn University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment141
Start date1 January 2020
Primary completion30 April 2020
Estimated completion15 June 2020
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Chulalongkorn University

Who can join

Eligibility, any sex, with Human Papilloma Virus Infection or Pterygium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prevalence of HPV-associated eye infection and cytokine levels in tears from patients diagnosed with pterygium

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Human Papilloma Virus Infection

Currently open trials in the same condition.

Other Chulalongkorn University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04117386.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing